Neuromuscular Blocking Agent Cisatracurium Attenuates Lung Injury by Inhibition of Nicotinic Acetylcholine Receptor-α1
ANESTHESIOLOGY, pp. 132-140, 2015.
Background: Neuromuscular blocking agents (NMBAs) bind the nicotinic acetylcholine receptor alpha 1 (nAChR alpha 1) that also contributes to inflammatory signaling. Thus, the author hypothesized that the use of NMBA mitigates lung injury by improving ventilator synchrony and decreasing inflammatory responses. Methods: Lung injury was indu...More
Full Text (Upload PDF)
PPT (Upload PPT)